Meiji Pharma Spain — FDA Facility Profile

FEI 3003184440

Meiji Pharma Spain is an FDA-registered facility (FEI 3003184440) located in Alcala de Henares Madrid, ES. RegDataLab tracks 4 FDA inspections and 1 compliance action at this facility.

Reviewing Meiji Pharma Spain as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Meiji Pharma Spain yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Dec 15, 2016: Voluntary Action Indicated (VAI)
Inspections on record
4 (1 OAI, 3 VAI)
Last OAI inspection
Jul 22, 2011
Warning letters
1 listed by FDA for this FEI, latest Apr 24, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 15, 2016Voluntary Action Indicated (VAI)Production processes (21 CFR 820.70(a))
Lack of or inadequate process validation (21 CFR 820.75(a))
Dec 12, 2014Voluntary Action Indicated (VAI)No citations listed
Nov 22, 2012Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Training--operations, GMPs, written procedures (21 CFR 211.25(a))
Written procedures not established/followed (21 CFR 211.67(b))
input/output verification (21 CFR 211.68(b))
and 1 more
Jul 22, 2011Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Equipment Design, Size and Location (21 CFR 211.63)
Procedures for non-sterile drug products (21 CFR 211.113(a))
Failing drug products not rejected (21 CFR 211.165(f))
and 3 more

Facility details

Company
Tedec-Meiji Farma, S.A.
Location
Alcala de Henares Madrid (ES)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.